These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 9522984)
21. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control; 1995 Apr; 23(2):87-94. PubMed ID: 7639408 [TBL] [Abstract][Full Text] [Related]
22. High incidence of virulence determinants, aminoglycoside and vancomycin resistance in enterococci isolated from hospitalized patients in Northwest Iran. Haghi F; Lohrasbi V; Zeighami H BMC Infect Dis; 2019 Aug; 19(1):744. PubMed ID: 31455296 [TBL] [Abstract][Full Text] [Related]
23. Virulence profiles of vancomycin-resistant enterococci isolated from surface and ground water utilized by humans in the North West Province, South Africa: a public health perspective. Matlou DP; Bissong MEA; Tchatchouang CK; Adem MR; Foka FET; Kumar A; Ateba CN Environ Sci Pollut Res Int; 2019 May; 26(15):15105-15114. PubMed ID: 30924038 [TBL] [Abstract][Full Text] [Related]
28. Spread of vancomycin-resistant enterococci: differences between the United States and Europe. Goossens H Infect Control Hosp Epidemiol; 1998 Aug; 19(8):546-51. PubMed ID: 9758053 [TBL] [Abstract][Full Text] [Related]
30. Assessment of testing for and completeness of reporting of vancomycin-resistant enterococci--Connecticut, 1994. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1996 Apr; 45(14):289-91. PubMed ID: 8598826 [TBL] [Abstract][Full Text] [Related]
31. Emergence of High-level Gentamicin Resistance among Labibzadeh M; Kaydani GA; Savari M; Ekrami A Pol J Microbiol; 2018; 67(4):401-406. PubMed ID: 30550226 [TBL] [Abstract][Full Text] [Related]
32. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Fridkin SK; Edwards JR; Courval JM; Hill H; Tenover FC; Lawton R; Gaynes RP; McGowan JE; Ann Intern Med; 2001 Aug; 135(3):175-83. PubMed ID: 11487484 [TBL] [Abstract][Full Text] [Related]
33. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Wells CL; Juni BA; Cameron SB; Mason KR; Dunn DL; Ferrieri P; Rhame FS Clin Infect Dis; 1995 Jul; 21(1):45-50. PubMed ID: 7578758 [TBL] [Abstract][Full Text] [Related]
34. Characterization of clinical enterococci isolates, focusing on the vancomycin-resistant enterococci in a tertiary hospital in China: based on the data from 2013 to 2018. Zhou W; Zhou H; Sun Y; Gao S; Zhang Y; Cao X; Zhang Z; Shen H; Zhang C BMC Infect Dis; 2020 May; 20(1):356. PubMed ID: 32517758 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study. Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H; J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703 [TBL] [Abstract][Full Text] [Related]
36. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities. Michel M; Gutmann L Lancet; 1997 Jun; 349(9069):1901-6. PubMed ID: 9217771 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients. Kang Y; Vicente M; Parsad S; Brielmeier B; Pisano J; Landon E; Pettit NN Transpl Infect Dis; 2013 Oct; 15(5):466-73. PubMed ID: 23911080 [TBL] [Abstract][Full Text] [Related]
38. Selective isolation of vancomycin-resistant enterococci. van Horn KG; Gedris CA; Rodney KM J Clin Microbiol; 1996 Apr; 34(4):924-7. PubMed ID: 8815109 [TBL] [Abstract][Full Text] [Related]
39. [In vitro activity of linezolid and dalbavancin against vancomycin-resistant enterococci]. Aktaş G; Bozdoğan B; Derbentli S Mikrobiyol Bul; 2012 Jul; 46(3):359-65. PubMed ID: 22951648 [TBL] [Abstract][Full Text] [Related]